home / stock / psyg:cc / psyg:cc news

PSYG:CC News and Press, Psyence Group Inc.

Stock Information
Company Name: Psyence Group Inc.
Stock Symbol: PSYG:CC
Market: CNQC
Website: psyence.com
Menu
PSYG:CC PSYG:CC Quote PSYG:CC Short PSYG:CC News PSYG:CC Articles PSYG:CC Message Board
Get PSYG:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
PSYG:CC - Canadian Companies Moving the Markets, Morning edition
Mon, Jul 15, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada Corus Entertainment Inc. Class B Non-Voting Shares (CJR.B) fell 15.0% to $0.17 on volume of 3,291,578 shares None (NFLD) rose 5.6% to $0.095 on volume of 2,281,965 shares Royal Bank of Canada (RY) rose 0.2% to $151.81 on volume of 1,501,977 shar...
PSYG:CC - Canadian Companies Moving the Markets, Morning edition
Fri, Jul 12, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) rose 0.2% to $76.905 on volume of 5,972,682 shares Bee Vectoring Technologies International (BEE) fell 33.3% to $0.01 on volume of 2,133,333 shares Earth Alive Clean Technologies Inc. (EAC) rose 0.0% to $0.015 on...

PSYG:CC - Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGEN? CRO to Train Research Therapists for Phase IIb Psilocybin Trial

NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group ") (CSE: PSYG), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to announce that its NASDAQ listed associate, Psyence Biomedical...

PSYG:CC - Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Further to the announcement by Psyence Group Inc (" Psyence " or the " Company ") (CSE:PSYG) of its plans for the strategic restructuring of its non-clinical business through a conditional M&A transaction (the " Transaction "), Psyence i...
PSYG:CC - Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study  

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group ") (CSE: PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to announce that its NASDAQ listed associate, Psy...

PSYG:CC - Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division

TORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- Further to the announcement by Psyence Group Inc (" Psyence Group " or the " Company ") (CSE:PSYG) of the closing (the "Closing") of the business combination of its subsidiary, Psyence Biomedical Ltd (" PBM ") ( NASDAQ : PBM ) with N...

PSYG:CC - Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (“Psyence Biomed”) is excited to announce the completion of its merger (the “Business Combination”) with Newcourt Acquisition Corp ("Newcourt"), a special purpose acquisition company. The Business Combi...
PSYG:CC - Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination

TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group") (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, today announced that its subsidiary, Psyence Biomedical Ltd ("Pubco"), has...

PSYG:CC - Psyence Group Announces Resignation of Board Member

TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG) (“ Psyence ” or the “ Company ”), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing announced today tha...

PSYG:CC - Canadian Investment Regulatory Organization Trade Resumption - PSYG

Canadian Investment Regulatory Organization Trade Resumption - PSYG Canada NewsWire VANCOUVER, BC , Nov. 15, 2023 /CNW/ - Trading resumes in: Company: Psyence Group Inc. CSE Symbol: PSYG All Issues: Yes Resumption (ET): 1:30 pm CIR...
Next 10